Market Indices
Sector Heatmap
MBRX — Moleculin Biotech, Inc.
NasdaqMoleculin Biotech, Inc.
- O
- 0.49
- H
- 0.49
- L
- 0.44
- V
- 705.89K
MBRX — Latest News & Headlines
12 StoriesMBRX Stock Drops 25% As Moleculin Biotech's Interim Cancer Trial Data Falls Short Of Significance - Stocktwits
MBRX Stock Drops 25% As Moleculin Biotech's Interim Cancer Trial Data Falls Short Of Significance Stocktwits
A leukemia trial finished enrolling 89 people. Full results are expected in early 2027. - Stock Titan
A leukemia trial finished enrolling 89 people. Full results are expected in early 2027. Stock Titan
Moleculin Biotech CS (MBRX-Q) Stock Price and News - The Globe and Mail
Moleculin Biotech CS (MBRX-Q) Stock Price and News The Globe and Mail
A review found no signs of heart damage in 90 patients given a cancer drug - Stock Titan
A review found no signs of heart damage in 90 patients given a cancer drug Stock Titan
Certain Pre-Funded Warrants of Moleculin Biotech, Inc. are subject to a Lock-Up Agreement Ending on 3-OCT-2026. - www.marketscreener.com
Certain Pre-Funded Warrants of Moleculin Biotech, Inc. are subject to a Lock-Up Agreement Ending on 3-OCT-2026. www.marketscreener.com
A cancer drug may help immune cells attack pancreatic tumors, early tests suggest. - Stock Titan
A cancer drug may help immune cells attack pancreatic tumors, early tests suggest. Stock Titan
Moleculin Biotech stock reaches 89-patient MIRACLE milestone2d4f8a6b-9c3e-4f1a-b7d2-5e8c0a6f3b91 - AD HOC NEWS
Moleculin Biotech stock reaches 89-patient MIRACLE milestone2d4f8a6b-9c3e-4f1a-b7d2-5e8c0a6f3b91 AD HOC NEWS
What’s Sending SNAP Shares Up Today? - Stocktwits
What’s Sending SNAP Shares Up Today? Stocktwits
Moleculin Biotech stock fell 2.10 percent on October 5 - AD HOC NEWS
Moleculin Biotech stock fell 2.10 percent on October 5 AD HOC NEWS
Moleculin Biotech Updates Investors With New Presentation - TipRanks
Moleculin Biotech Updates Investors With New Presentation TipRanks
Moleculin Completes Enrollment in Pivotal AML Trial - TipRanks
Moleculin Completes Enrollment in Pivotal AML Trial TipRanks
Moleculin Highlights Annamycin Cardiac Safety in New Analysis - TipRanks
Moleculin Highlights Annamycin Cardiac Safety in New Analysis TipRanks